id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-004919-d7tilk8v	Baker, Rahaf	Macrophage activation syndrome in a patient with axial spondyloarthritis on adalimumab	2018-12-07		.txt	text/plain	1869	105	42	MAS is a potentially fatal syndrome that can present in patients with inflammatory conditions and is considered to be similar to hemophagocytic lymphohistiocytosis (HLH) [1, 2] . The most consistent diagnosis for our patient was MAS, as he had high persistent fevers without an infectious cause, lymphopenia and anemia, marked hyperferritinemia, hypertriglyceridemia, splenomegaly, and the presence of hemophagocytes on bone marrow biopsy. It is plausible that adalimumab triggered MAS in our patient as he presented at 2.5 months after initiation of adalimumab, which is consistent with the timeline from other case reports, and he had no obvious infection. Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab Possible macrophage activation syndrome following initiation of adalimumab in a patient with adult-onset still's disease	./cache/cord-004919-d7tilk8v.txt	./txt/cord-004919-d7tilk8v.txt